Xu Y - Search Results

1

Benzo[d]isoxazole Derivatives as Hypoxia-Inducible Factor (HIF)-1α Inhibitors.

Xue Z, Li H, Xie W, Xu Y, Zhou L, Qu ZB. Xue Z, et al. Among authors: xu y. ACS Med Chem Lett. 2022 Sep 13;13(12):1864-1869. doi: 10.1021/acsmedchemlett.2c00308. eCollection 2022 Dec 8. ACS Med Chem Lett. 2022. PMID: 36518694 Free PMC article.

2

Strategic development of a self-adjuvanting SARS-CoV-2 RBD vaccine: From adjuvant screening to enhanced immunogenicity with a modified TLR7 agonist.

Meng X, Xu Y, Yang J, Meng S, Ding N, Sun T, Zong C. Meng X, et al. Among authors: xu y. Int Immunopharmacol. 2024 May 10;132:111909. doi: 10.1016/j.intimp.2024.111909. Epub 2024 Mar 29. Int Immunopharmacol. 2024. PMID: 38554446

3

Efficient synthesis of α-galactosylceramide and its C-6 modified analogs.

Li H, Mao H, Chen C, Xu Y, Meng S, Sun T, Zong C. Li H, et al. Among authors: xu y. Front Chem. 2022 Nov 25;10:1039731. doi: 10.3389/fchem.2022.1039731. eCollection 2022. Front Chem. 2022. PMID: 36505742 Free PMC article.

4

The synthesis and preliminary immunological evaluation of a dual-adjuvant SARS-CoV-2 RBD vaccine: Covalent integration of TLR7/8 and iNKT cell agonists.

Xu Y, Yang J, Meng X, Meng S, Sun T, Ding N, Zong C. Xu Y, et al. Int J Biol Macromol. 2024 Jun;270(Pt 1):132258. doi: 10.1016/j.ijbiomac.2024.132258. Epub 2024 May 10. Int J Biol Macromol. 2024. PMID: 38735613

5

Discovery of a novel OGT inhibitor through high-throughput screening based on Homogeneous Time-Resolved Fluorescence (HTRF).

Wu X, Wang M, Cao Y, Xu Y, Yang Z, Ding Y, Lu J, Zheng J, Luo C, Zhao K, Chen S. Wu X, et al. Among authors: xu y. Bioorg Chem. 2023 Oct;139:106726. doi: 10.1016/j.bioorg.2023.106726. Epub 2023 Jul 8. Bioorg Chem. 2023. PMID: 37451145

6

ChatGPT Performs on the Chinese National Medical Licensing Examination.

Wang X, Gong Z, Wang G, Jia J, Xu Y, Zhao J, Fan Q, Wu S, Hu W, Li X. Wang X, et al. Among authors: xu y. J Med Syst. 2023 Aug 15;47(1):86. doi: 10.1007/s10916-023-01961-0. J Med Syst. 2023. PMID: 37581690

7

The role of MAPK pathway in gastric cancer: unveiling molecular crosstalk and therapeutic prospects.

Yuan W, Shi Y, Dai S, Deng M, Zhu K, Xu Y, Chen Z, Xu Z, Zhang T, Liang S. Yuan W, et al. Among authors: xu y. J Transl Med. 2024 Dec 24;22(1):1142. doi: 10.1186/s12967-024-05998-8. J Transl Med. 2024. PMID: 39719645 Review.

8

Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis.

Lu L, Cai S, Zhu H, Liu G, Wang Y, Ren P, Lan L, Shen X, Chen L, Xu Y, Cheng J, Li X, Chen J, Han F. Lu L, et al. Among authors: xu y. BMC Nephrol. 2024 Dec 24;25(1):473. doi: 10.1186/s12882-024-03912-4. BMC Nephrol. 2024. PMID: 39719585

9

Comment on the Article: Risk of pneumonia-related hospitalization after initiating angiotensin-converting enzyme inhibitors compared with angiotensin II receptor blockers: a retrospective cohort study using LIFE Study data.

He M, Xu Y, Liu C. He M, et al. Among authors: xu y. Hypertens Res. 2024 Dec 24. doi: 10.1038/s41440-024-02074-y. Online ahead of print. Hypertens Res. 2024. PMID: 39719532 No abstract available.

10

Molecular mechanism of culinary herb Artemisia argyi in promoting lifespan and stress tolerance.

Wang J, Zhu D, Cui H, Xu Y, Shang S, Miao Y, Xu Z, Li R. Wang J, et al. Among authors: xu y. NPJ Sci Food. 2024 Dec 24;8(1):111. doi: 10.1038/s41538-024-00358-8. NPJ Sci Food. 2024. PMID: 39719452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,032 results

Search Page

Filters